Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26

J Control Release. 2008 Jun 4;128(2):120-7. doi: 10.1016/j.jconrel.2008.03.007. Epub 2008 Mar 14.

Abstract

A novel drug carrier for brain delivery, poly(ethyleneglycol)-poly(epsilon-caprolactone) (PEG-PCL) polymersomes conjugated with mouse-anti-rat monoclonal antibody OX26 (OX26-PO), was developed and its brain delivery property was evaluated. The diblock copolymers of methoxy-PEG-PCL and Maleimide-PEG-PCL were synthesized and applied to prepare polymersomes (PO) which were verified by direct cryogenic temperature transmission electron micrograph (Cryo-TEM) imaging. The TEM examination and dynamic light scattering results showed that OX26-PO had a round and vesicle-like shape with a mean diameter around 100 nm. Coupling of OX26 with PO was confirmed by immuno-gold labeling of OX26 visualized under the TEM and X-ray photoelectron spectroscopy test. The surface OX26 densities were obtained from enzyme-linked immunosorbant assay. The result of brain delivery in rats proved that the increase of surface OX26 density of OX26-PO decreased blood AUC. The optimized OX26 number conjugated per polymersome was 34, which can acquire the greatest blood-brain barrier (BBB) permeability surface area product and percentage of injected dose per gram brain (%ID/g brain). Furthermore, NC-1900, as a model peptide, was encapsulated into OX26(34)-PO and improved the scopolamine-induced learning and memory impairments in a water maze task via i.v. administration. These results indicated that OX26(34)-PO is a promising carrier for peptide brain delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / immunology
  • Area Under Curve
  • Biological Availability
  • Brain / metabolism*
  • Coumarins / chemistry
  • Coumarins / pharmacokinetics
  • Cryoelectron Microscopy
  • Electron Probe Microanalysis
  • Lactones / chemical synthesis
  • Lactones / chemistry
  • Learning Disabilities / chemically induced
  • Learning Disabilities / prevention & control
  • Maze Learning / drug effects
  • Memory Disorders / chemically induced
  • Memory Disorders / prevention & control
  • Microscopy, Immunoelectron
  • Nanocapsules / chemistry*
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacokinetics*
  • Oligopeptides / therapeutic use
  • Particle Size
  • Polyesters / chemical synthesis
  • Polyesters / chemistry
  • Polyethylene Glycols / chemical synthesis
  • Polyethylene Glycols / chemistry
  • Polymers / chemical synthesis
  • Polymers / chemistry*
  • Pyrrolidonecarboxylic Acid / analogs & derivatives*
  • Pyrrolidonecarboxylic Acid / chemistry
  • Pyrrolidonecarboxylic Acid / pharmacokinetics
  • Pyrrolidonecarboxylic Acid / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Transferrin / immunology
  • Scopolamine / pharmacology

Substances

  • Antibodies, Monoclonal
  • Coumarins
  • Lactones
  • NC 1900
  • Nanocapsules
  • Oligopeptides
  • Polyesters
  • Polymers
  • Receptors, Transferrin
  • methoxy poly(ethylene glycol-co-epsilon-caprolactone)
  • poly(ethylene glycol)-block-poly(epsilon-caprolactone)
  • Polyethylene Glycols
  • Scopolamine
  • Pyrrolidonecarboxylic Acid